Síntesis y caracterización de nanocelulosas de orígenes diversos

The main aim of this Project is the synthesis and characterization of nanocelluloses from different sources: biotechnological, natural, and finally, chemical. To achieve this objective, it was necessary a previous theoretical introduction explaining the concepts related with cellulose and nanocellulose. In case of cellulose, it has been studied the chemical structure, the polymorphism and properties. In case of nanocellulose, it has been deeply studied its types, its different applications and the methodology to obtain nanocellulose from raw materials, reaction times and experimental procedure. With the aid of a bibliographic search, it is explained in a detailed way all the synthesis that were carried out in this project with its reagents, purification methods and additional processes such as sonication. The yield obtained in the biotechnological synthesis, the natural and finally the chemical synthesis was 4,33 g/L, 0,57% and 10%, respectively. It is important to stand out that, in the natural synthesis, it was not possible to carry out a measure of the dried raw material that is the reason why it has low yield. Thanks to spectroscopic analysis of the synthetized samples from laboratory, and the samples provided by Cellulose Lab and Borregaard, the nanocelluloses were compared and the peaks from IR in all cases were quite similar. In the case of XRD and SEM, the results confirm that there are samples that contain nanocellulose such as nata de coco and the chemical synthesis, obtaining CNF and CNC, respectively. Histograms were made from samples which were fibrous, to deeply study the size and how SEM pictures vary depending on samples. It was realized and economic study and an environmental impact study that causes the realization of this project. Finally, this project concludes both general and particular objectives were achieved by synthetizing and analyzing different samples of nanocellulose of different origins

O Papel dos Alergénios Moleculares no Diagnóstico de Síndrome Gato-Porco: A Propósito de um Caso Clínico Raro

Cats; Food Hypersensitivity; SwineGats; Hipersensibilitat alimentària; PorcsGatos; Hipersensibilidad alimentaria; PuercosCat-pork syndrome is a rare condition, with few cases reported in the literature. This syndrome is justified by the homology between serum albumins from cat and pork. Evidence suggests that a primary sensitization to cat serum albumin Fel d 2 occurs, followed by allergic reactions after ingestion of pork meat containing serum albumin Sus s 1. Due to homology between other mammalian serum albumins, reactions with other meats can also be present. We report a well-documented case report of a patient with cat-pork syndrome, with initial mild and non-specific manifestations to well-cooked pork that were overlooked. Component resolved diagnosis was essential to establish the diagnosis, which confirmed the involvement of Fed 2 and Sus s 1, but less relevant in helping to define avoidance diets, since the sensitization profile was not in accordance with clinical manifestations

PFC Buque CON-RO-RO 1400 m lineales

Tipo de buque:CON-RO-RO Capacidad de carga Carga 1:1400 metros lineales Carga 2:500 TEU's sobre cubierta Peso Muerto:7500 tpm Sociedad de Clasificación:Bureau Veritas Cámara Desatendida Reglamentos:Solas-2009, Marpol, Convenio Líneas de Carga Velocidad:18 nudos al 85% MCR en pruebas Autonomía:8000 millas al 90% MCR y 15% margen de mar Tripulación:25 persona

Specific sublingual immunotherapy with peach LTP (Pru p 3). One year treatment: a case report

INTRODUCTION: Food allergy is an increasing problem with limited therapeutic approaches apart from to the eviction diet. CASE PRESENTATION: A 40-year-old female patient with food allergy symptoms was polysensitized to almost all vegetable food since the age of 36; the onset of symptoms was during pregnancy. The allergological study demonstrated positive skin prick tests (SPT) to nuts, legumes, cereals, spices, several fresh fruits including peach, and other groups of vegetable foods however, it was negative to common aeroallergens. Serum specific IgE levels were negative (<0.35 kU/L) to profilin and carbohydrate determinants, but positive to Pru p 3 (3.5 kU/L). Positive double-blind placebo-controlled food challenge to peach confirmed the allergic disease. She received specific sublingual immunotherapy with native Pru p 3 at a concentration of 40 mug/ml with 5 administrations per week and a cumulative dose of 200 mug of nPru p 3 per month. After an ultra-rush build-up phase concluded in one day she continued therapy during a year with 5 administrations per week. The clinical evolution and laboratory studies demonstrated an early reduction on SPT reactions with no relevant changes on serum specific IgE, IgG, IgG(1) and IgG(4) to Pru p 3 during the immunotherapy period. The challenge test was negative 4 months after the beginning of the SLIT. Regarding clinical response she markedly improved after the first month of treatment, and by the 3th month she had no major vegetable dietary restrictions, except for nuts and pepper. CONCLUSION: These results demonstrate the excellent efficacy and safety of sublingual specific protein immunotherapy developed according to the patient specific sensitivity profile to Pru p3

Decreased salivary lactoferrin levels are specific to Alzheimer's disease

Background: Evidences of infectious pathogens in Alzheimer's disease (AD) brains may suggest a deteriorated innate immune system in AD pathophysiology. We previously demonstrated reduced salivary lactoferrin (Lf) levels, one of the major antimicrobial proteins, in AD patients. Methods: To assess the clinical utility of salivary Lf for AD diagnosis, we examine the relationship between salivary Lf and cerebral amyloid-beta (A beta) load using amyloid-Positron-Emission Tomography (PET) neuroimaging, in two different cross-sectional cohorts including patients with different neurodegenerative disorders. Findings: The diagnostic performance of salivary Lf in the cohort 1 had an area under the curve [AUC] of 0.95 (0.911-0.992) for the differentiation of the prodromal AD/AD group positive for amyloid-PET (PET+) versus healthy group, and 0.97 (0.924-1) versus the frontotemporal dementia (FTD) group. In the cohort 2, salivary Lf had also an excellent diagnostic performance in the health control group versus prodromal AD comparison: AUC 0.93 (0.876-0.989). Salivary Lf detected prodromal AD and AD dementia distinguishing them from FTD with over 87% sensitivity and 91% specificity. Interpretation: Salivary Lf seems to have a very good diagnostic performance to detect AD. Our findings support the possible utility of salivary Lf as a new non-invasive and cost-effective AD biomarker.This study was supported by Dr. Carro grants from Instituto de Salud Carlos III (FIS15/00780, FIS18/00118), FEDER, Comunidad de Madrid (S2017/BMD-3700; NEUROMETAB-CM), and CIBERNED (PI2016/01). This study was also supported by research grants from the Spanish Ministry of Economy and Competitiveness (SAF201785310-R to Dr. Cantero, PSI2017-85311-P to Dr. Atienza); International Centre on ageing CENIE-POCTEP (0348_CIE_6_E to Dr. Atienza); and CIBERNED (CB06/05/1111 to Dr. Cantero). Dr. Bueno receives research funding from the Instituto de Salud Carlos III, Spain (PIE16/00021, PI17/01799). The H2H-Spain Study was supported in Spain by grant PIE16/00021 from Instituto Carlos III, Ministry of Science, Innovation and Universities, and additional funds from the Centro Nacional de Investigaciones Cardiovasculares (CNIC). The CNIC is supported by the Ministry of Economy, Industry and Competitiveness and the Pro CNIC Foundation, and is a Severo Ochoa Centre of Excellence (SEV-2015-0505). The funders had no role in the conceptualisation, study design, data collection analysis and preparation of this manuscript

Assessment of cardioresporatory fitness in preschool children: adaptation of the 20 metres shuttle run test

La capacidad cardiorrespiratoria es un potente indicador de salud presente y futura en niños y adolescentes, sin embargo se desconoce si también lo es para niños de edad preescolar, de 3 a 5 años. En el presente estudio, describimos la adaptación a preescolares del test original de 20m de ida y vuelta, su viabilidad y asimilación en niños de 3 a 5 años, así como su maximalidad y fiabilidad. Un total de 130 alumnos (4,91 ± 0,89 años; 77 niños), realizaron el test dos veces, con dos semanas de separación. La adaptación del test consistió principalmente en reducir la velocidad inicial de 8,5 km/h a 6,5 km/h. El test fue viable y tuvo una buena asimilación tanto en niños como en niñas y en los tres grupos de edad, 3, 4 y 5 años. La frecuencia cardíaca máxima (FCmáx) alcanzada para la muestra completa fue de 199,4 ± 12,5 latidos/minuto, equivalente a un 97% de la FCmáx teórica estimada, y sin diferencias significativas por sexo o edad. La diferencia de medias test-retest (error sistemático) en el número de vueltas alcanzado fue de 2 vueltas, sin diferencias por sexo o edad. No hubo evidencia de heterocedasticidad. Nuestros resultados sugieren que el test es máximo y fiable en este grupo de edad. Futuros estudios de intervención o longitudinales que utilicen este test deberían tener en cuenta que cambios en el rendimiento en el test de 2 vueltas podrían deberse a la propia variabilidad de la medida, mientras que cambios de mayor magnitud podrían ser atribuibles a la intervención o cambios asociados a la edad.Cardiorespiratory fitness is a strong indicator of present and future health in children and adolescents, however it is unknown whether it is for pre-schoolers, from 3 to 5 years. In the present study, we described the adaptation of the original 20m shuttle run test, it feasibility and acceptance in children from 3 to 5 years and its maximality and reliability. A total of 130 students (4.91 ± 0.89 years; 77 boys) performed the test twice, two weeks apart. The test adaptation consisted mainly in reducing the initial speed of 8.5 km/h to 6.5 km/h. The test was feasible and was well accepted in both boys and girls and the three age groups, 3, 4 and 5 years. The maximum heart rate (MHR) achieved for the entire sample was 199.4 ± 12.5 beats/min, equivalent to 97% of the estimated theoretical MHR, and no significant differences by gender or age. Mean test-retest difference (systematic error) in the number of laps achieved was 2 laps, with no significant differences between sex or age. There was no evidence of heteroscedasticity. Our results suggest the test is maximum and reliable in this age group. Future longitudinal or intervention studies using this test should take into account that changes in the test performance of 2 laps may be due to the variability of the measure, while wider changes would be attributable to the intervention or changes associated with age

Mortality prediction in chronic obstructive pulmonary disease comparing the GOLD 2015 and GOLD 2019 staging: a pooled analysis of individual patient data

In 2019, The Global Initiative for Chronic Obstructive Lung Disease (GOLD) modified the grading system for patients with COPD, creating 16 subgroups (1A–4D). As part of the COPD Cohorts Collaborative International Assessment (3CIA) initiative, we aim to compare the mortality prediction of the 2015 and 2019 COPD GOLD staging systems. We studied 17 139 COPD patients from the 3CIA study, selecting those with complete data. Patients were classified by the 2015 and 2019 GOLD ABCD systems, and we compared the predictive ability for 5-year mortality of both classifications. In total, 17 139 patients with COPD were enrolled in 22 cohorts from 11 countries between 2003 and 2017; 8823 of them had complete data and were analysed. Mean±sd age was 63.9±9.8 years and 62.9% were male. GOLD 2019 classified the patients in milder degrees of COPD. For both classifications, group D had higher mortality. 5-year mortality did not differ between groups B and C in GOLD 2015; in GOLD 2019, mortality was greater for group B than C. Patients classified as group A and B had better sensitivity and positive predictive value with the GOLD 2019 classification than GOLD 2015. GOLD 2015 had better sensitivity for group C and D than GOLD 2019. The area under the curve values for 5-year mortality were only 0.67 (95% CI 0.66–0.68) for GOLD 2015 and 0.65 (95% CI 0.63–0.66) for GOLD 2019

Sensibilización y formación en la accesibilidad e inclusión de las personas con discapacidad visual al proceso de Enseñanza-Aprendizaje. SENSIVISUAL-UCM

El objetivo general de este proyecto viene definido por la necesidad de inclusión de las personas con discapacidad visual, parcial o absoluta, en el mundo académico, así como la de favorecer su incorporación al mundo laboral con unas condiciones formalizadas y estables. A través de las acciones realizadas en este proyecto de innovación y mejora de la calidad docente se podrá mejorar la accesibilidad en los diferentes Grados de la Universidad Complutense de Madrid, ayudando en la generación de material didáctico y composición de grupos de trabajo que fomenten el trabajo colaborativo permitiendo el re-fuerzo académico

RICORS2040 : The need for collaborative research in chronic kidney disease

Chronic kidney disease (CKD) is a silent and poorly known killer. The current concept of CKD is relatively young and uptake by the public, physicians and health authorities is not widespread. Physicians still confuse CKD with chronic kidney insufficiency or failure. For the wider public and health authorities, CKD evokes kidney replacement therapy (KRT). In Spain, the prevalence of KRT is 0.13%. Thus health authorities may consider CKD a non-issue: very few persons eventually need KRT and, for those in whom kidneys fail, the problem is 'solved' by dialysis or kidney transplantation. However, KRT is the tip of the iceberg in the burden of CKD. The main burden of CKD is accelerated ageing and premature death. The cut-off points for kidney function and kidney damage indexes that define CKD also mark an increased risk for all-cause premature death. CKD is the most prevalent risk factor for lethal coronavirus disease 2019 (COVID-19) and the factor that most increases the risk of death in COVID-19, after old age. Men and women undergoing KRT still have an annual mortality that is 10- to 100-fold higher than similar-age peers, and life expectancy is shortened by ~40 years for young persons on dialysis and by 15 years for young persons with a functioning kidney graft. CKD is expected to become the fifth greatest global cause of death by 2040 and the second greatest cause of death in Spain before the end of the century, a time when one in four Spaniards will have CKD. However, by 2022, CKD will become the only top-15 global predicted cause of death that is not supported by a dedicated well-funded Centres for Biomedical Research (CIBER) network structure in Spain. Realizing the underestimation of the CKD burden of disease by health authorities, the Decade of the Kidney initiative for 2020-2030 was launched by the American Association of Kidney Patients and the European Kidney Health Alliance. Leading Spanish kidney researchers grouped in the kidney collaborative research network Red de Investigación Renal have now applied for the Redes de Investigación Cooperativa Orientadas a Resultados en Salud (RICORS) call for collaborative research in Spain with the support of the Spanish Society of Nephrology, Federación Nacional de Asociaciones para la Lucha Contra las Enfermedades del Riñón and ONT: RICORS2040 aims to prevent the dire predictions for the global 2040 burden of CKD from becoming true